olga-latinovic
Olga S. Latinovic
Assistant Professor
  • : 410-706-2769    : 410-760-1992   

Department for Microbiology and Immunology
University of Maryland School of Medicine, Institute of Human Virology
USA

Education

1999 MSc1, University of Belgrade, Physics
2001 MSc2, Lehigh University, Physics
2006 PhD, Lehigh University, Physics

Post Graduate Education and Training

2005-2006 Postdoctoral Fellow, Division of Basic Science,Institute of Human Virology, University of Maryland Biotechnology Institute, Dr. G. Melikian.
2006-2007 Research Associate, Institute of Human Virology, University of Maryland Biotechnology Institute, Dr. G. Melikian/ Dr. R. R. Redfield, Division of Basic Science/Clinical division.
2007-2010 Research Associate, Institute of Human Virology, University of  Maryland School of Medicine, Dr. R. R. Redfield/ Dr. R.C. Gallo/ Dr. G. Melikian, Division of Basic Science/Clinical division.
2013 IACUC approved protocol and complete training for work with SCID/NOD mice # 0213014

 

Biography

Dr. Olga Latinovic received her M. Sc (2001) and Ph.D (2006) from Lehigh University, USA, where she was awarded the Sherman Fairchild scholarship for outstanding academic performance. As of 2010, she is an assistant professor working at the Institute of Human Virology led by Robert C. Gallo, M.D. at the University of Maryland, School of Medicine in Baltimore, USA. She heads the Laboratory for Imaging Studies of Pathogens and Host Cells Interactions. Dr. Latinovic’s research focus is on HIV-1 entry and its inhibition into host target cells, particularly focusing on the CCR5 coreceptor which plays a major role in HIV-1 infection and is consequently an attractive target for anti-viral therapy. Dr. Latinovic wrote the book Micromechanics and Structure of Soft and Biological Materials, published by Verlag Dr. Muller in 2010, and co-authored the bookHandbook of Photonics for Biomedical Engineering published bySpringer-Verlag in 2013. Dr. Latinovic has lectured at various national/international conferences, and is on the Editorial Board of three scientific journals. She is a member of several national and international scientific societies.

 

Research Interest

 

Professional Activities:

Professional Society Memberships

2000-2006    

American Physical Society

2004–2009   

American Biophysical Society

2004-2005   

American Biomedical Engineering Society

2005

Polymer Networks Society

Mentorship

  • 2002-2005 Lab work training and mentoring of Research Summer    students at Lehigh University, (5 undergraduate students): Optical tweezers microrheology and microscopy of biological materials.
  • 2009  Supervising visiting summer student, Surendra Kumar, from  Indian Institute for Technology, Bioengineering Department, Cell- cell fusion phenomena- Melikian Lab, Department of   Microbiology and Immunology, University of Maryland.
  • 2009  Supervising Ph.D student on Rotation program at the IHV:  Patrick Padair from Department of Microbiology and Immunology,  University  of Maryland,  Rous Sarcoma Virus Endocytosis project-Melikian Lab, University of Maryland.
  • 2010 Supervising an undergrad student at the IHV, Mary Bolggiano-Summer intern on  HIV Entry Inhibitors project  - Redfield lab, University of Maryland.
  • 2012-2013 Supervising an undergrad student at the IHV, Michael Rubenstein, volunteer at IHV, on HIV Entry Inhibitors project, University of Maryland.

 

Publications

Peer-reviewed journal articles

  1. Z.V. Popovic, A. Cantarero, J. Camacho, A. Milutinovic, O. Latinovic,  L. Gonzalez,  “Raman scattering and infrared reflectivity in an [(InP)14(In0.49Ga0.51As)23] superlattice”, The Journal of Applied Physics, Volume 88, 6382-6386 (2000).
  2. H. M. Moawad, J. Toulouse, H. Jain, O. Latinovic and A. R. Kortan, "Local Structure and Vibrational Spectra of Doped Tellurite Glasses," Ceramic Transactions (Optoelectronic Materials Technology in the Information Age), Volume 126, 45-57 (2002).
  3. H. D. Ou-Yang , M. Mengistu, O. Latinovic, A. Kumar and C. Pu, Oscillating Optical Tweezer-Based 3-D Confocal Microrheometer for Investigating the Intracellular Micromechanics and Structures”, 46th SPIE Conference, San Diego, California,  the Journal in SPIE proceedings, (2005).
  4. A. Heredia, B. Gilliam, O. Latinovic, N. Le, D. Bamba, A. DeVico, G.B. Melikian, R. C. Gallo and R. R. Redfield, Rapamycin reduces CCR5 density levels on CD4 T cells and this effect results in potentiation of Enfuvirtide (T-20) against R5 HIV-1 in vitro”, Antimicrobial Agents and Chemotherapy, Volume 51, No.7, 2489-2496 (2007).
  5. A. Heredia, O. Latinovic, R. C. Gallo, G. B. Melikian, M. Reitz, N. Le and R. R. Redfield, Low doses of Rapamycin enhance the antiviral activity of CCR5 antagonist VCV against wild-type and drug resistant R5 HIV-1, (co-first authorship), Proceeding of the National Academy of Sciences, Volume 105, No. 51, 20476-20481 (2008).
  6. K. Miyauchi, Y. Kim, O. Latinovic, V. Morozov and G. B. Melikian, HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes, Cell, Volume 137, Issue 3, 433-444 (2009).
  7. O. Latinovic, A. Heredia, Robert C. Gallo, Marv Reitz, Nhut Le and Robert R. Redfield, Low doses of the immunomodulatory drug Rapamycin decrease the anti-HIV effective dose of the CCR5 antagonist Aplaviroc: potential clinical implications, (co-first authorship), Antiviral Research, Volume 83, 86-89 (2009).
  8. O. Latinovic, J. Kuruppu, C. Davis, N. Lee and A. Heredia, Pharmacotherapy of HIV-1 Infection:  Focus on CCR5 antagonist Maraviroc, Review for Clinical Medicine: Therapeutics, Volume 1, 1497-1510 (2009).
  9. O. Latinovic, L. A. Hough and H. D. Ou-Yang, Structural and Micromechanical Properties of Collagen Type I, The Journal of Biomechanics, Volume 43, Issue 3, 500-505 (2010).
  10. O. Latinovic, M. Reitz, N. Le, J. S. Foulke, G. Fatkenheuer, C. Lehmann, H. Valdez, R. R. Redfield and A. Heredia, CCR5 antibodies HGS004 and HGS101 inhibit Maraviroc-resistant HIV-1 and Inhibition is more potent in the presence of Maraviroc: Clinical Implications, Virology, 411, 32-40 (2011).
  11. N. Jha, O. Latinovic, E. Martin, G. Novitskiy, M, Marin, K. Miyauchi, J. Naughton,  J. A. T. Young and G.B. Melikyan, Imaging single retrovirus entry through  alternative receptor isoforms and intermediate virus-cell fusion, PloS Pathogens, Volume  7, Issue 1, 1001260 (2011).
  12. O. Latinovic, N. Le, M. Reitz, R. Pal, A. DeVico, J. S. Foulke, R. R. Redfield and     A. Heredia, Synergistic Inhibition of CCR5-tropic HIV-1 by Maraviroc and CCR5 Antibody HGS004 in Primary Cells: Potential Implications for Treatment and Prevention,  AIDS, 1;25(9):1232-5 (2011).
  13.  F. Cocchi, A. L. DeVico, W. Lu, M. Popovic, O. Latinovic, M. M. Sajadi, R. R.    Redfield, M. K. Lafferty, M. Galli, A. Garzino-Demo and R. C. Gallo, The Soluble Factors from T Cells Inhibiting X4 Strains of HIV are a Mixture of b Chemokines and RNases, Proceeding of the National Academy of Sciences, Volume 109 (14):5411-6 (2012).
  14. O. Latinovic, J. Zhang, Y. Tagaya, A. L. DeVico, T. Fouts, K. Schneider, J. Lakowicz, A. Heredia and  R. R. Redfield, Synergistic inhibition of R5 HIV-1 by Maraviroc and FLSC IgG in primary cells: Implications for prevention and treatment- sent to Current HIV Research.
  15.  O. Latinovic, K. Schneider, H. Szmacinski, J. R. Lakowicz, A. Heredia and R. R. Redfield, Binding of fusion protein FLSC IgG1 to CCR5 is enhanced by CCR5 antagonist Maraviroc, Antiviral Research, Volume 112: 80-90 (2014).
  16.  F. Obata, P. B. Subrahmanyam, A. E. Vozenilek, L. M. Hippler, T. Jeffers, M. Tongsuk, I. Tiper, P. Saha, D. M. Jandhyala,G. L. Kolling, O. Latinovic and T.J. Webb, Natural Killer T (NKT) cells accelerate Shiga toxin type 2 (Stx2) pathology in mice, accepted in Infection and Immunity.
  17.  F. Obata, L. M. Hippler, P. Saha, D. M. Jandhyala  and O. Latinovic, Shiga toxin type-2 (Stx2) induces glutamate release via phosphoinositide 3-kinase (PI3K) pathway in murine neurons, sent to Frontiers of Molecular Neuroscience.
  18. D. Zella, S. Curreli, S. Krishnan, F. Romerio, L.J. Tallon, D. Riley, O. Latinovic, N. Kumar, M. Charurat, J. Carneiro Da Silva,  M. Djavani, C. Fraiser, J. Bryant, H. Tettelin and R.C Gallo, Mycoplasma infection induces tumorigenesis in vivo, sent to Nature.
  19. J. P. Bharucha, M. Lafferty, O. Latinovic, W. Lu, S. Gartner, A. Garzino-Demo, Human beta-defensin 2 inhibits HIV-1 replication in primary macrophages via induction of APOBEC3 family anti-retroviral restriction factors, in preparation.
  20. A. Heredia, O. Latinovic, F. Barbault,  E. P. H. deLeeuw, A Novel Small Molecule Inhibitor of HIV Entry, sent to Retrovirology.
  21. D. Basta, O. Latinovic, M. K. Lafferty, L. Sun, J. Bryant,  A. Caruso, R. Gallo, A. Garzino-Demo, Angiogenic, lymphoangiogenic and adipogenic effects of HIV-1 Matrix protein p17 Ugandan variant,  to be sent for publishing.
  22. S. Curreli, O. Latinovic, N. Stamatos, Semaphorins 3A and #F Induce F-actin Reorganization in Human Dendritic Cells: Role in Cell Migration,  under the second review in Journal of Leuk Biol.
  23.  H.Szmacinski, K. Schneider, O. Latinovic, Direct detection of secretion of HIV virus from infected HeLa cells usin plasmonic substrates and microscopy methodologies, in preparation.
  24. O. Latinovic, S. Medina-Moreno, K. Schneider, N. Gohain, J. Zapata, M. Pazgier, M. Reitz, J. Bryant, R.R. Redfield, Full length single chain Fc protein (FLSC IgG1) as a potent anti-viral therapy candidate: Implications for in vivo studies, sent to AIDS Research and Human Retroviruses.

Non-peer-reviewed journal articles

  1. . Z. V. Popovic, A. Cantarero, J. Camacho, A. Milutinovic, O. Latinovic,   L. Gonzalez,  Raman Scattering and Infrared Spectroscopy of GaAs/AlAs Superlattices”, Technique,  No. 2 , 1E, Belgrade’s Press, (1999).
  2. Y. Kim, K. Miyauchi, O. Latinovic,  G. Melikian, Imaging Single Virus Fusion Reveals the HIV1 Entry Pathway, Biophysical Journal, Volume 96, No. 3, pp. 357a, (2009).
  3. O. Latinovic, Rapamycin enhances the antiviral activity of CCR5 antagonist    Vicriviroc, JAIDS - JAIDS- Journal of Acquired Immune Deficiency Syndromes, Volume 51, (2009).
  4. K. Miyauchi, Y. Kim, O. Latinovic, G. Melikian,  Diverse Enveloped Viruses Fail to Undergo Complete Fusion with the Cell Plasma Membrane, Biophysical Journal, Volume 98, No. 3, pp. 615a, (2010).

Books

  1. Olga Latinovic, Micromechanics and Structure of Soft and Biological Materials: An Optical Tweezers Study - Verlag Dr. Muller, ISBN (978-3-639-23050-5), 2010.
  2. Ming-Tzo Wei, O. Latinovic, L. A. Hough, Y.-Q. Chen, H. D. Ou-Yang, A. Chiou, "Studying microrheology of soft and living materials using optical trapping," in Handbook of Photonics for Biomedical Engineering, Kim, Donghyun; Ho, Aaron H.-P.; Somekh, Michael G. (Eds.), Springer-Verlag, Berlin, (2014). ISBN 978-94-007-5053-1.

Abstracts and/or Proceedings

  1. Z. V. Popovic, A. Cantarero, J. Camacho, A. Milutinovic, O. Latinovic,  L. Gonzalez, “Phonons in InP/InGaAs Superlattices”, American Physical Society, Minneapolis, March 2000.
  2. O. Latinovic, L. A. Hough, H. D. Ou-Yang, “Microrheology of Poly(ethylene Oxide) Solutions: A Comparison between the Results obtained from Brownian Noise Spectra and from Forced Oscillation Measurements”, American Physical Society, Indianapolis, March 2002.
  3. O. Latinovic, L. A. Hough, H. D. Ou-Yang, “Microrheology of Poly (ethylene Oxide) Solutions”, American Physical Society, Montreal, March 2004.
  4. O. Latinovic,  H. D. Ou-Yang, “Microrheology of Collagen Type I Gels”, NIH Polymer Network Society, Bethesda , August 2004.
  5. O. Latinovic,  H. D. Ou-Yang, “Microrheology of Collagen Type I Gels”, Biomedical Engineering Society, Philadelphia , October 2004.
  6. O. Latinovic, H. D. Ou-Yang, “Active and Passive Microscopic Viscoelastic Response in Poly (ethylene) Oxide Solutions”, American Physical Society, Baltimore, March 2006.
  7. C. Perretta, S.  Farrell, O. Latinovic, H. D. Ou-Yang, “Internal Structure, Fluctuations and Micromechanical Properties of Bovine Endothelial Cells: An Optical Tweezers Study”, American Physical Society, Baltimore, March 2006.
  8. O. Latinovic, H. D. Ou-Yang, “Fluctuations and Dissipation in a Viscoelastic Media”, American Biophysical Society, Long Beach, February 2005.
  9. O. Latinovic, H. D. Ou-Yang, “Inhomogeneity of Type I Collagen Gels”, American Biophysical Society, Long Beach, February 2005.
  10. O. Latinovic, L. A. Hough, H. D. Ou-Yang, “Inhomogeneity of Type I Collagen Gels”, American Physical Society, Los Angeles, March 2005.
  11. O. Latinovic, A. Heredia, N. Le,  D. Bamba, A. De Vico, G. Melikian,  R. C. Gallo, R. Redfield,"CCR5 density levels on primary CD4 T cells impact the replication and Enfuvirtide susceptibility of R5 HIV-1",  10th IHV Annual conference, Baltimore, November 2006.
  12. A. Heredia, O. Latinovic,  N. Le,  D. Bamba, A. De Vico, G. Melikian,  R. C. Gallo, R. Redfield, "The immunomodulatory drug Rapamycin potentiates the antiviral activity of the fusion inhibitor Enfuvirtide (T-20) against R5 HIV-1 in vitro", The 14th Conference on Retroviruses and Opportunistic Infections, Los Angeles, February 2007.
  13. O. Latinovic, A. Heredia, N. Le,  D. Bamba, A. De Vico, G. Melikian,  R. C. Gallo, R. Redfield,  "The immunomodulatory drug Rapamycin potentiates the antiviral activity of the fusion inhibitor Enfuvirtide (T-20) against R5 HIV-1 by reducing CCR5 density levels on CD4 T-cells", American Biophysical Society Conference, Baltimore, March 2007.
  14. Y. Kim, K. Miyauchi, O. Latinovic and G. B. Melikian, Imaging of single virus fusion reveals the HIV-1 entry pathway, American Biophysical Society Conference, Boston, March 2009.
  15. Y. Kim, K. Miyauchi, O. Latinovic and G. B. Melikian, Productive HIV-1 entry occurs via fusion with endosomes but not with the plasma membrane,  Cold Spring Harbor Lab Meeting on Retroviruses, Cold Spring Harbor, NY, May 2009.
  16. K. Miyauchi, Y. Kim, O. Latinovic and G. B. Melikian, HIV-1 enters cells via receptor-mediated endocytosis followed by Env- and Dynamin-dependant fusion with endosomes, Cold Spring Harbor Lab Meeting on Retroviruses, NY, May 2009.
  17. O. Latinovic, Rapamycin enhances the antiviral activity of CCR5 antagonists Vicriviroc, JAIDS-Journal of Acquired Immune Deficiency Syndroms, Volume 51, June 2009.
  18. N. Jha, E. Martin, O. Latinovic, G. Novitskiy, M. Marin,  K. Miayuchi, and G. B. Melikyan, Distinct entry pathways of an avian virus into cells expressing transmembrane and GPI-anchored receptor isoforms, American Biophysical Society,  Baltimore, March 2011.
  19.  O. Latinovic, M. Reitz, N. Le, J. S. Foulke, G. Fätkenheuer, C. Lehmann, R. R.      Redfield and A. Heredia, CCR5 Antibodies HGS004 and HGS101 Preferentially Inhibit Drug-bound CCR5 Infection and Restore Drug Sensitivity of Maraviroc-resistant HIV-1 in Primary Cells, CROI, Feb 2011. 
  20. O. Latinovic, A. Heredia, R. C. Gallo, and R. R. Redfield, Suppression of CCR5   Density as a Novel Way to Enhance the Anti-HIV Activity of Fusion Inhibitors and CCR5 Antagonists, JAIDS-Journal of Acquired Immune Deficiency Syndroms, Volume 56, Issue 5, p52, April 2011.
  21. M.K. Lafferty, J. Bharucha, O. Latinovic, L. Sun, W. Royal, S. Gartner, W. Lu and A. Garzino-Demo,  Inhibition of HIV infection in highly susceptible cells with human Beta-defensins-induction of APOBEC3G via chemokine receptors, 13th IHV International Conference, poster, Baltimore, November 2011.
  22. W. Royal III, J. Bryant, M. Guo, H. Davis and O. Latinovic,  Oxiditive Stress, Proinflamatory Responses and HIV Expression in the HIV-1 Transgenic Rat, ISVN Symposium 2012, New Your City, May 2012.
  23. M.K. Lafferty, J. Bharucha, O. Latinovic, L. Sun, W. Royal, S. Gartner, W. Lu and A. Garzino-Demo, Human Beta-Defensins 2 and 3 inhibit HIV in macrophages: Implications for HIV infection in the CNS, ISVN Symposium 2012, New Your City, May 2012.
  24. Jennifer P. Bharucha, Mark Lafferty, Olga Latinovic, Wuyuan Lu, Suzanne Gartner  and Alfredo Garzino-Demo, Human -defensin 2 inhibits HIV-1 replication in primary macrophages via induction of the APOBEC3 family anti-retroviral restriction factors, Keystone Symposia on "Immune Activation in HIV Infection: Basic Mechanisms and Clinical Implications, Breckenridge, CO, USA, April  2013.

Major Invited Speeches

International

  1. H. M. Moawad, J. Toulouse, H. Jain, O. Latinovic, and A.R. Kortan, “Local Structure and Vibrational Raman Spectra of Doped Tellurite Glasses”, American Ceramic Society 103rd Meeting, Indianapolis, April 2001.
  2. O. Latinovic, Rapamycin enhances the anti-HIV activity of CCR5 antagonist Vicriviroc, Selected talk for the 11th IHV International Conference, Baltimore, September 2008.
  3. O. Latinovic, A. Heredia, R. C. Gallo and R. R. Redfield, “Suppression of CCR5 density as a novel way to enhance the anti-HIV activity of fusion inhibitors and CCR5 antagonists”, Selected talk for the 12th IHV International Conference, Calabria, Italy, October 2010.
  4. O. Latinovic, N. Le, A. Heredia and R.R. Redfield, The CCR5 Antibodies HGS004 and HGS101 preferentially inhibit drug-bound CCR5 infection and Restore Drug Sensitivity of Maraviroc-Resistant HIV-1 in Primary Cells, Selected talk for the 13th IHV International Conference, poster, Baltimore, November 2011.
  5.  O. Latinovic, K. Schneider, H. Szmacinski, J. Lakowicz, A, Heredia and R.R.    Redfield, Binding of fusion protein FLSC IgG1 to CCR5 is enhanced by CCR5 antagonist Maraviroc, Selected talk for the 16th IHV International Conference, poster, Baltimore, September 2014.
  6. M. Popovic, J. Bryant, O. Latinovic, S. Curreli, R.C. Gallo and Y. Tagaya, Detection and Characterization of leukemia stem-like cells in Adult T-cell Leukemia (ATL), Selected talk for the 16th IHV International Conference, poster, Baltimore, September 2014.
  7. S. Medina-Moreno, O. Latinovic, K. Schneider, N. Gohain, J. Zapata, M. Pazgier, M. Reitz, J. Bryant, R.R. Redfield, Full length single chain Fc protein (FLSC IgG1) as a potent anti-viral therapy candidate: Implications for in vivo studies, 34th Annual Meeting of the American Society of Virology, July 2015.

National

  1. O. Latinovic,  A. Heredia,  G. Melikian,  R. Redfield, R. C. Gallo, Cell-Cell Fusion and Virus-Cell Fusion Characterized by Imaging and Flow Cytometry Techniques, Bioimaging Conference,  Lehigh University, September 2006.
  2. O. Latinovic, A. Heredia, G. Melikian, R. C. Gallo, R. Redfield,  “Novel approaches for characterization of virus entry into host cells”, Center for Optical Technologies Conference,  Lehigh University, October 2008.

Local

  1. O. Latinovic, invited lecture for Profectus Biosciences- FLSC IgG1 enhances the anti-viral activity of Maraviroc (CCR5 Antagonist) in HIV-1 entry inhibition, June 2013.
  2. O. Latinovic, invited lecture at St. Mary’s University- Novel methods to characterize and inhibit HIV entry, April, 2013.
  3. O. Latinovic, Novel Approaches in antiretroviral therapy, the IHV Board of Advisors Meeting, Washington DC, April 2008.
  4. O. Latinovic, The role of CCR5 in HIV Entry: From the cell surface through the internalization pathway, Department Microbiology and Immunology Seminar-invited, University of Maryland School of Medicine, December 2011.

Proffered Communications

  1. J. Toulouse, O. Latinovic, R. Kortan, “Comparative Raman Study of the Local Units and Network Structures of Different Oxide Glasses”, Glass&Optical Materials Division Meeting, Corning , NY, October 2000.
  2. O. Latinovic,  L. A. Hough,  H. D. Ou-Yang, “Validation of Microrheology of Poly(ethylene Oxide) Solutions”, 5th National Graduate Research Polymer Conference, Bethlehem , June 2003.
  3. O. Latinovic, H. D. Ou-Yang, “Structural and Micromechanical characterization of Type I Collagen Gels”, 16th Annual St. Joseph Un. Research Symposium”, Philadelphia, April 2005.
  4. O. Latinovic,  H. D. Ou-Yang, “Microscopic Viscoelastic Response in Poly(ethylene) Oxide Solutions”, 16th Annual St. Joseph Un. Research Symposium”, Philadelphia, April 2005.
  5. O. Latinovic, E. Rickter, M. Mengistu,  A. Kumar, H. C. Yalcin, J. Wang, Y. J. Huang, L. Lowe-Krentz, H. D. Ou-Yang, “Biophotonics of Soft / Biological Materials at Cellular and Molecular Levels”, Center for Optical Technology conference, Lehigh University, Bethlehem, May 2005.
  6. H. Yalcin, S. Ghadiali, O. Latinovic,  H. D. Ou-Yang, “Quantification of Epithelial Cell Injury during Ventilation Treatment”, Center for Optical Technology Open house/workshop, Lehigh University, Bethlehem, May 2005.
  7. C. Perretta, S.  Farrell, O. Latinovic, H. D. Ou-Yang, “Internal Structure and Micromechanical Properties of Bovine Endothelial Cells”, Center for Optical Technology conference, Lehigh University, Bethlehem, May 2006.
  8. O. Latinovic, Alonso Heredia, Robert C. Gallo and Robert R. Redfield, “Reduction of CCR5 density as a strategy to enhance the antiviral activity of entry inhibitors”, IHV Annual Retreat, Baltimore, November 2007.
  9. O. Latinovic, “Reduction of CCR5  density as a strategy to enhance the anti-HIV activity of entry inhibitors”, IHV Annual Retreat, Baltimore,  October 2008.
  10. O. Latinovic, A. Heredia, R. C. Gallo and R. R. Redfield, “Suppression of CCR5 density as a novel way to enhance the antiviral activity of HIV entry inhibitors”, IHV Annual Retreat, Baltimore,  October 2009.
  11. F. Cocchi, A. L. DeVico, A. Garzino-Demo, O. Latinovic, R. C. Gallo, “ The b Chemokines MDC, TARC and I-309 are an Important Component of the Soluble Anti- X4 Activity Secreted by CD4+ and CD8+T cells”,  poster for the 12th IHV International Conference, Calabria, Italy, October 2010.
  12. O. Latinovic, A. Heredia, R. C. Gallo and R. R. Redfield, “Reduction of CCR5 density as a strategy to enhance the antiviral activity of entry inhibitors: CCR5 antagonist resistant versus sensitive virus”, IHV Annual Retreat, Baltimore,  Nov 2010.

 

Autoimmune Journal Flyer